Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
5.47M
-
Shares change
-
+559K
-
Total reported value, excl. options
-
$102M
-
Value change
-
+$15.8M
-
Number of buys
-
40
-
Number of sells
-
-17
-
Price
-
$18.67
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2019
64 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q4 2019.
XBiotech Inc. - Common Shares, no par value (XBIT) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.47M shares
of 30.8M outstanding shares and own 17.77% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.75M shares), VANGUARD GROUP INC (989K shares), GEODE CAPITAL MANAGEMENT, LLC (336K shares), STATE STREET CORP (335K shares), Sofinnova Investments, Inc. (241K shares), NORTHERN TRUST CORP (231K shares), D. E. Shaw & Co., Inc. (176K shares), ClariVest Asset Management LLC (162K shares), MILLENNIUM MANAGEMENT LLC (139K shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (88.8K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.